A rational approach to obtaining high-specific polyclonal antibodies against recombinant alpha-synuclein

   
Barinova K.V.1, Melnikova A.K.2, Schmalhausen E.V.3, Muronetz V.I.4

1. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia; Sechenov First Moscow State Medical University, Institute of Molecular Medicine, Moscow, Russia
2. Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia
3. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia
4. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20186403276      PubMed Id: 29964265
Year: 2018  Volume: 64  Issue: 3  Pages: 276-282
The approach for the quick and efficient production ofpolyclonal antibodies tothe target antigen alpha-synuclein has been proposed. Two methods have been employed to purify specific rabbit polyclonal antibodies against recombinant human alpha-synuclein, produced by subcutaneous immunization with complete Freund's adjuvant. It was shown that purification on CNBr-activated Sepharose with immobilized alpha-synuclein resulted in antibody preparation with rabbit serum histidine-rich glycoprotein as a contaminant. Two-stage antibody purification procedure first on Sepharose with immobilized protein G, and then on alpha-synuclein immobilized column helps to avoid contamination and to obtain homogenous antibody preparation. Antibodies recognize different conformations of alpha-synuclein and can be used in a variety of immunochemical approaches, including immunocytochemistry.
Download PDF:  
Keywords: polyclonal antibodies, alpha-synuclein, adjuvant, immunization
Citation:

Barinova, K. V., Melnikova, A. K., Schmalhausen, E. V., Muronetz, V. I. (2018). A rational approach to obtaining high-specific polyclonal antibodies against recombinant alpha-synuclein. Biomeditsinskaya Khimiya, 64(3), 276-282.
This paper is also available as the English translation: 10.1134/S1990750818040029
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)